Dow Down 0.68% Nasdaq Down 0.42%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
0.91 Down 0.04(4.23%) 4:00PM EDT
|After Hours : 0.80 Down 0.11 (11.60%) 4:30PM EDT
Prev Close:0.95
Open:0.93
Bid:0.85 x 1000
Ask:4.98 x 100
1y Target Est:3.50
Beta:1.07
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:0.90 - 0.97
52wk Range:0.65 - 4.00
Volume:356,732
Avg Vol (3m):409,406
Market Cap:54.90M
P/E (ttm):N/A
EPS (ttm):-0.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMUC

Comparison

Symbol% ChgMkt Cap
IMUCDown 4.23%54.90M
AGENDown 2.08%176.75M
DNDNDown 1.95%234.70M
STMLUp 2.47%155.48M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback